Melior Licenses Novel Diabetes Drug to Bukwang Pharmaceutical Co.

RECENT POSTS

• Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger Populations
• Latus Bio to Present New Data at ASGCT 2026 Supporting Investigational Gene Therapy Approaches for Huntington’s Disease and CLN2 Disease
• Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectrum Respiratory Endpoint Solutions for Life Sciences